Skip to Main Content

Paper Details

Physician risk perceptions and surveillance practices for tyrosine kinase inhibitor long-term effects in pediatric CML.
Pediatric Hematology and Oncology
2
2022
Author NameAffiliation
Edward A KolbNemours/Alfred I. duPont Hospital for Children, Nemours Center for Cancer and Blood Disorders
  • 1 - 1

Datasets

Release 1.2